What Researchers Did
The author reviewed ways to check blood flow and oxygen in the skin near diabetic foot ulcers, and argued for which test works best when deciding who should get hyperbaric oxygen therapy.
What They Found
This review article argues that transcutaneous oximetry, a test that measures oxygen levels in tissue, is better than other point-of-care screening tests for guiding hyperbaric oxygen therapy in diabetic foot ulcers. The abstract reports no sample size, trial results or numerical data. It says hyperbaric oxygen has been used for diabetic foot ulcers for more than four decades and is supported by some high-quality evidence, but that conflicting data leave its use open to criticism. The author states that testing with both air and oxygen can show locally reversible hypoxia, and that oximetry can tell responders from non-responders early by detecting new blood vessel growth. The author also states that near-infrared spectroscopy and long-wave infrared thermography do not guide treatment in the same way.
What This Means for Canadian Patients
For people with diabetic foot ulcers, the abstract suggests that better patient selection is a recurring concern when hyperbaric oxygen is considered. It argues that oximetry testing could help decide who continues treatment and when to stop, instead of continuing until the wound closes. These are the author's arguments, not results from a new trial, so patients should talk with their care team about testing and treatment plans.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This is a narrative review that presents the author's argument for one test, reports no new patient data, and acknowledges that evidence for hyperbaric oxygen in diabetic foot ulcers is conflicting.